表观遗传年龄与危重症患者结局的关联
本研究为巢式病例对照研究的二次分析,纳入加拿大四家三级医院的危重症脓毒症与非脓毒症患者,利用全血DNA甲基化数据以Hannum和PhenoAge算法推算表观遗传年龄及其与实足年龄的偏差。66例脓毒症患者中34例男性(51.5%),平均年龄65.03岁,25例(37.8%)出院前死亡;68例非脓毒症患者中47例男性(69.1%),平均年龄64.92岁,25例(36.7%)出院前死亡。PhenoAge算法显示脓毒症患者表观遗传年龄显著加速4.97年(p=0.045),非脓毒症患者无显著加速;合并队列中死亡者加速7.62年(p=0.004),存活者无显著加速。Hannum算法在脓毒症、非脓毒症及存活与死亡比较中均未显示显著加速。结论认为PhenoAge算法计算的表观遗传年龄加速与脓毒症诊断和死亡相关。
要点
- PhenoAge算法显示脓毒症患者表观遗传年龄显著加速4.97年(p=0.045),非脓毒症患者无显著加速。
- 合并脓毒症与非脓毒症队列中,死亡者PhenoAge表观遗传年龄加速7.62年(p=0.004),存活者无显著加速。
- Hannum算法在脓毒症或非脓毒症患者中均未显示显著年龄加速。
- Hannum算法下存活状态与年龄加速无关联。
- 脓毒症患者出院前死亡率37.8%(25/66),非脓毒症患者36.7%(25/68)。
适用人群与场景
- 加拿大四家三级医院的危重症脓毒症与非脓毒症患者。
- 脓毒症患者66例,其中男性34例(51.5%),平均年龄65.03岁。
- 非脓毒症患者68例,其中男性47例(69.1%),平均年龄64.92岁。
研究设计与关键结果
- 研究设计为巢式病例对照研究的二次分析,利用全血DNA甲基化数据,以Hannum和PhenoAge算法推算表观遗传年龄及与实足年龄的偏差。
- 脓毒症患者出院前死亡25例(37.8%),非脓毒症患者出院前死亡25例(36.7%)。
- PhenoAge算法显示脓毒症患者表观遗传年龄显著加速4.97年(p=0.045),非脓毒症患者无显著加速。
- Hannum算法在脓毒症或非脓毒症患者中均未显示显著年龄加速。
- 合并队列中,死亡者PhenoAge表观遗传年龄加速7.62年(p=0.004),存活者无显著加速;Hannum算法下存活状态与年龄加速无关联。
证据类型、等级与局限
- 证据类型:巢式病例对照研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在危重症患者中,PhenoAge算法计算的表观遗传年龄加速与脓毒症诊断和死亡相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: DNA methylation can be used to determine an individual's biological age, as opposed to chronological age, an indicator of underlying health status. This study aimed to assess epigenetic age in critically ill patients with and without sepsis to determine if higher epigenetic age is associated with admission diagnosis or mortality.
DESIGN: Secondary analysis of whole blood DNA methylation data generated from a nested case-control study of critically ill septic and nonseptic patients.
SETTING: Four tertiary care hospitals in Canada.
INTERVENTIONS: None.
PATIENTS: Critically ill patients with and without sepsis.
MEASUREMENTS AND MAIN RESULTS: Epigenetic age was derived from DNA methylation data using the Hannum and PhenoAge algorithms and deviation from the patient's chronological age in years was determined. Of the 66 patients with sepsis, 34 were male (51.5%), the mean age was 65.03 years and 25 patients (37.8%) died before discharge. Of the 68 nonseptic patients, 47 were male (69.1%), the mean age was 64.92 years and 25 (36.7%) died before discharge. Epigenetic age calculated using the PhenoAge algorithm showed a significant age acceleration of 4.97 years in septic patients (p = 0.045), but no significant acceleration in nonseptic patients. Epigenetic age calculated using the Hannum algorithm showed no significant acceleration in the septic or nonseptic patients. Similarly, in the combined septic and nonseptic cohorts, nonsurvivors showed an epigenetic age acceleration of 7.62 years (p = 0.004) using the PhenoAge algorithm while survivors showed no significant age acceleration. Survivor status was not associated with age acceleration using the Hannum algorithm.
CONCLUSIONS: In critically ill patients, epigenetic age acceleration, as calculated by the PhenoAge algorithm, was associated with sepsis diagnosis and mortality.
参考来源
- Sharma-Oates A, Sullivan J, Pestana D, et al. Association of Epigenetic Age and Outcome in Critically Ill Patients. Crit Care Explor. 2024. PMID: 38343441. doi:10.1097/CCE.0000000000001044
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。